SVB, Solar Capital Provide Up to $20MM to ATyr Pharma
ATyr Pharma amended its $20 million credit agreement with lenders Silicon Valley Bank and Solar Capital.
July 6, 2017
aTyr Pharma | Silicon Valley Bank | Solar Capital
Sam Nickerson
SVB, Solar Capital Provide $20MM Facility to aTyr Pharma
aTyr Pharma entered into a $20 million credit facility with Silicon Valley Bank and Solar Capital. aTyr intends to use the additional capital to pay off existing indebtedness and for general corporate purposes.
November 22, 2016
SVB Provides Venture Debt to aTyr Pharma
aTyr Pharma closed $10 million debt financing from SVB to support the clinical development of aTyr’s first therapeutic program to treat rare autoimmune diseases and a rare disease pipeline in immune disorders.
July 30, 2013